Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Next generation sequencing for liquid biopsy based testing in non-small cell lung cancer in 2021
Pasquale Pisapia, José Luís Costa, Francesco Pepe, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 161, pp. 103311-103311
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Liquid Biopsy in Prostate Cancer Management—Current Challenges and Future Perspectives
Felice Crocetto, Gianluca Russo, Erika Di Zazzo, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3272-3272
Open Access | Times Cited: 78
The evolving role of liquid biopsy in lung cancer
Umberto Malapelle, Pasquale Pisapia, Francesco Pepe, et al.
Lung Cancer (2022) Vol. 172, pp. 53-64
Closed Access | Times Cited: 48
miRNA as biomarker in lung cancer
Esperanza Salcedo Lobera, Macarena Arroyo Varela, Rafael Larrosa Jiménez, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 11, pp. 9521-9527
Open Access | Times Cited: 25
Liquid biopsy in lung cancer
Lan Li, Haixia Jiang, Bingjie Zeng, et al.
Clinica Chimica Acta (2024) Vol. 554, pp. 117757-117757
Closed Access | Times Cited: 14
Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study
Pasquale Pisapia, Francesco Pepe, Anna Baggi, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 169, pp. 103525-103525
Closed Access | Times Cited: 52
Blood-based liquid biopsy: Insights into early detection and clinical management of lung cancer
Cuiliu Liu, Xiaoqiang Xiang, Shuangqing Han, et al.
Cancer Letters (2021) Vol. 524, pp. 91-102
Closed Access | Times Cited: 49
Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer
Umberto Malapelle, Pasquale Pisapia, Alfredo Addeo, et al.
Expert Review of Molecular Diagnostics (2021) Vol. 21, Iss. 11, pp. 1165-1178
Closed Access | Times Cited: 42
The evolving landscape of anatomic pathology
Pasquale Pisapia, Vincenzo L’Imperio, Francesca Galuppini, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 178, pp. 103776-103776
Closed Access | Times Cited: 31
Current challenges and practical aspects of molecular pathology for non-small cell lung cancers
Paul Hofman, Sabina Berezowska, Daniel Kazdal, et al.
Virchows Archiv (2023) Vol. 484, Iss. 2, pp. 233-246
Open Access | Times Cited: 20
Liquid Biopsy for Biomarker Testing in Non-Small Cell Lung Cancer: A European Perspective
Umberto Malapelle, Marcello Tiseo, Ana Vivancos, et al.
Journal of Molecular Pathology (2021) Vol. 2, Iss. 3, pp. 255-273
Open Access | Times Cited: 29
Exploring the potential of multiomics liquid biopsy testing in the clinical setting of lung cancer
Andrea Gottardo, Tancredi Didier Bazan Russo, Alessandro Perez, et al.
Cytopathology (2024) Vol. 35, Iss. 6, pp. 664-670
Open Access | Times Cited: 4
RET rearrangements in non-small cell lung cancer: Evolving treatment landscape and future challenges
Alberto Servetto, Daniela Esposito, Roberto Ferrara, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 6, pp. 188810-188810
Closed Access | Times Cited: 19
A novel photosensitive nanoprobe combined with CRISPR/Cas12a for dual signal amplification detection of ANGPTL2
Xiuyu Chen, Dan Zhao, Changmin Yu, et al.
Talanta (2025), pp. 128010-128010
Closed Access
Hype or hope – Can combination therapies with third-generation EGFR-TKIs help overcome acquired resistance and improve outcomes in EGFR-mutant advanced/metastatic NSCLC?
Filippo Papini, Janani Sundaresan, Alessandro Leonetti, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 166, pp. 103454-103454
Open Access | Times Cited: 21
Emerging noncoding RNAs contained in extracellular vesicles: rising stars as biomarkers in lung cancer liquid biopsy
Giuseppe Cammarata, Diego Pérez, Alessandro Russo, et al.
Therapeutic Advances in Medical Oncology (2022) Vol. 14, pp. 175883592211312-175883592211312
Open Access | Times Cited: 13
A narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma
Susana Hernández, Esther Conde, Marta Alonso de la Varga, et al.
Translational Lung Cancer Research (2023) Vol. 12, Iss. 7, pp. 1549-1562
Open Access | Times Cited: 8
Overview of the role of liquid biopsy in non-small cell lung cancer (NSCLC)
Aylen Vanessa Ospina
Clinical Oncology (2024) Vol. 36, Iss. 10, pp. e371-e380
Closed Access | Times Cited: 2
Circulating cell-free DNA sequencing for early detection of lung cancer
Ruyue Xue, Lu Yang, Meijia Yang, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 7, pp. 589-606
Closed Access | Times Cited: 6
The Performance of an Extended Next Generation Sequencing Panel Using Endobronchial Ultrasound-Guided Fine Needle Aspiration Samples in Non-Squamous Non-Small Cell Lung Cancer: A Pragmatic Study
Chenchen Zhang, Roger Y. Kim, Cindy McGrath, et al.
Clinical Lung Cancer (2022) Vol. 24, Iss. 2, pp. e105-e112
Open Access | Times Cited: 10
Case Report: A case of ultra-late recurrence of KIF13A-RET fusion non-small cell lung cancer response to selpercatinib
Ha-Young Park, Joo-Heon Park, Myung‐Geun Shin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer
Pasquale Pisapia, Francesco Pepe, Antonino Iaccarino, et al.
Journal of Molecular Pathology (2021) Vol. 2, Iss. 3, pp. 241-254
Open Access | Times Cited: 10
Mutation profile in liquid biopsy tested by next generation sequencing in Mexican patients with non-small cell lung carcinoma and its impact on survival
José Fabián Martínez‐Herrera, Gisela Sánchez Domínguez, Juan José Juárez‐Vignon Whaley, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 1, pp. 161-174
Open Access | Times Cited: 1
Recent advances in the use of liquid biopsy for the diagnosis and treatment of lung cancer
Valerio Gristina, Gianluca Russo, Tancredi Didier Bazan Russo, et al.
Expert Review of Respiratory Medicine (2024), pp. 1-11
Closed Access | Times Cited: 1
The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapies
Ilaria Attili, Marzia Del Re, Elena Guerini‐Rocco, et al.
Expert Review of Molecular Diagnostics (2021) Vol. 21, Iss. 8, pp. 757-766
Closed Access | Times Cited: 9
Implementation of the clinical practice of liquid biopsies for thoracic oncology the experience of the RespirERA university hospital institute (Nice, France)
Paul Hofman
The Journal of Liquid Biopsy (2023) Vol. 1, pp. 100004-100004
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top